Circ Res:血管重塑血管外膜sca1阳性祖细胞的来源及功能研究

2017-03-22 MedSci MedSci原创

血管外膜位于血管壁外层,是包含滋养微血管、神经、成纤维细胞、免疫细胞和原位祖细胞的复合层。外膜祖细胞表达干细胞标记物Sca1和CD34(外膜sca1阳性祖细胞简称AdvSca1),具有体外分化为多个谱系的潜力,并且可能促进体内内膜损伤。近日,美国学者发表题为《分化型平滑肌细胞依赖Klf4产生原位血管外膜祖细胞亚群》的研究文章于血管研究顶级期刊Circulation Research。越来越多的数据

血管外膜位于血管壁外层,是包含滋养微血管、神经、成纤维细胞、免疫细胞和原位祖细胞的复合层。外膜祖细胞表达干细胞标记物Sca1和CD34(外膜sca1阳性祖细胞简称AdvSca1),具有体外分化为多个谱系的潜力,并且可能促进体内内膜损伤。

近日,美国学者发表题为“分化型平滑肌细胞依赖Klf4产生原位血管外膜祖细胞亚群”的研究文章于血管研究顶级期刊Circulation Research。

越来越多的数据支持AdvSca1细胞的存在,本研究的目的是确定其起源、多能性和异质性,以及在血管重塑中的作用。

使用2种在体命运图谱分析方法并结合平滑肌细胞(SMC)表观遗传谱系标记,作者发现AdvSca1细胞亚群是由原位分化型SMC产生。数据证实血管外膜含有表型不同的表达SMC,骨髓和造血祖细胞样标记的祖细胞亚群,并且分化型SMC是不同程度的每种亚群的来源。 SMC来源的AdvSca1细胞表现出多潜能表型,即在体内可分化为成熟SMC,原位巨噬细胞和内皮样细胞。血管损伤后,SMC衍生的AdvSca1细胞数量增加促进外膜重塑。分化型SMC中转录因子Klf4激活对体内SMC的重编程是必需的,体外研究也发现Klf4对维持AdvSca1祖细胞表型是必需的。

分化型SMC产生原位血管祖细胞是正常的生理过程,构成血管干细胞池并在血管稳态及疾病中发挥重要作用。

原始出处:Majesky MW,Horita H,et al. Differentiated Smooth Muscle Cells Generate a Subpopulation of Resident Vascular Progenitor Cells in the Adventitia Regulated by Klf4. Circ Res. 2017 Jan 20;120(2):296-311.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1632986, encodeId=d4251632986a1, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Fri Mar 02 17:00:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793642, encodeId=4e4d1e936426d, content=<a href='/topic/show?id=82a715948b1' target=_blank style='color:#2F92EE;'>#Sca1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15948, encryptionId=82a715948b1, topicName=Sca1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Jul 20 23:00:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512421, encodeId=73a9151242111, content=<a href='/topic/show?id=f802e4102cb' target=_blank style='color:#2F92EE;'>#祖细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74102, encryptionId=f802e4102cb, topicName=祖细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18310470858, createdName=12498636m52(暂无昵称), createdTime=Thu Mar 23 15:00:00 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1632986, encodeId=d4251632986a1, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Fri Mar 02 17:00:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793642, encodeId=4e4d1e936426d, content=<a href='/topic/show?id=82a715948b1' target=_blank style='color:#2F92EE;'>#Sca1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15948, encryptionId=82a715948b1, topicName=Sca1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Jul 20 23:00:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512421, encodeId=73a9151242111, content=<a href='/topic/show?id=f802e4102cb' target=_blank style='color:#2F92EE;'>#祖细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74102, encryptionId=f802e4102cb, topicName=祖细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18310470858, createdName=12498636m52(暂无昵称), createdTime=Thu Mar 23 15:00:00 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
    2017-07-20 hbwxf
  3. [GetPortalCommentsPageByObjectIdResponse(id=1632986, encodeId=d4251632986a1, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Fri Mar 02 17:00:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793642, encodeId=4e4d1e936426d, content=<a href='/topic/show?id=82a715948b1' target=_blank style='color:#2F92EE;'>#Sca1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15948, encryptionId=82a715948b1, topicName=Sca1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Jul 20 23:00:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512421, encodeId=73a9151242111, content=<a href='/topic/show?id=f802e4102cb' target=_blank style='color:#2F92EE;'>#祖细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74102, encryptionId=f802e4102cb, topicName=祖细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18310470858, createdName=12498636m52(暂无昵称), createdTime=Thu Mar 23 15:00:00 CST 2017, time=2017-03-23, status=1, ipAttribution=)]

相关资讯

Nature:组织因子和PAR1促进肠道菌群诱导的血管重塑

瑞典哥德堡大学Sahlgrenska学院研究人员发现了肠道细菌影响血管形成的一种以前未知的机制。相关结果发表在《自然》杂志上,研究结果可能为未来肠道疾病和肥胖的治疗提供新思路。 我们的肠道细菌数量是人体细胞数量的十倍以上。然而,我们很少知道肠道菌群的功能以及这些菌群对我们生理上产生什么样的影响。 以前未知的机制 在小鼠动物模型的研究中,研究人员发现了肠道菌群如何影响肠道生理和血管重塑的以